 | Up a level |
Ripellino, P; Arányi, Z; van Alfen, N; Ventura, E; Peyer, A K; Cianfoni, A; Gobbi, C; Pedrick, E; Sneag, D B (2022). Imaging of Neuralgic Amyotrophy in the Acute Phase. Muscle & nerve, 66(6), pp. 709-714. John Wiley & Sons 10.1002/mus.27732
Danieli, L; Roccatagliata, L; Distefano, D; Prodi, E; Riccitelli, G C; Diociasi, A; Carmisciano, L; Cianfoni, A; Bartalena, T; Kaelin-Lang, A; Gobbi, C; Zecca, C; Pravatà, E (2022). Nonlesional Sources of Contrast Enhancement on Postgadolinium "Black-Blood" 3D T1-SPACE Images in Patients with Multiple Sclerosis. AJNR. American journal of neuroradiology, 43(6), pp. 872-880. American Society of Neuroradiology 10.3174/ajnr.A7529
Sacco, R; Disanto, G; Maraffi, I; Candrian, U; Kamm, Christian Philipp; Rossi, S; Schwegler, G; Gallo, A; Gobbi, C; Zecca, C (2020). Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period? Multiple Sclerosis and Related Disorders, 38, p. 101523. Elsevier 10.1016/j.msard.2019.101523
Kamm, Christian Philipp; Barin, L; Gobbi, C; Pot, C.; Calabrese, P; Salmen, Anke; Achtnichts, L; Kesselring, J; Puhan, M A; von Wyl, V. (2020). Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study. Journal of neurology, 267(1), pp. 153-161. Springer-Medizin-Verlag 10.1007/s00415-019-09563-y
Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073
Cereda, Cw; Zecca, C; Mazzucchelli, L; Valci, L; Staedler, C; Bassetti, Cl; Gobbi, C (2013). Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy. Multiple sclerosis journal, 19(6), pp. 820-3. London: Sage 10.1177/1352458512461969
